These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17968313)
1. Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313 [TBL] [Abstract][Full Text] [Related]
2. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Vallacchi V; Daniotti M; Ratti F; Di Stasi D; Deho P; De Filippo A; Tragni G; Balsari A; Carbone A; Rivoltini L; Parmiani G; Lazar N; Perbal B; Rodolfo M Cancer Res; 2008 Feb; 68(3):715-23. PubMed ID: 18245471 [TBL] [Abstract][Full Text] [Related]
3. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694 [TBL] [Abstract][Full Text] [Related]
4. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor. Böhlig L; Metzger R; Rother K; Till H; Engeland K Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052 [TBL] [Abstract][Full Text] [Related]
5. Matricellular proteins produced by melanocytes and melanomas: in search for functions. Fukunaga-Kalabis M; Santiago-Walker A; Herlyn M Cancer Microenviron; 2008 Dec; 1(1):93-102. PubMed ID: 19308688 [TBL] [Abstract][Full Text] [Related]
6. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349 [TBL] [Abstract][Full Text] [Related]
7. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736 [TBL] [Abstract][Full Text] [Related]
8. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells. Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729 [TBL] [Abstract][Full Text] [Related]
9. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092 [TBL] [Abstract][Full Text] [Related]
10. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts. Peidl A; Perbal B; Leask A PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244 [TBL] [Abstract][Full Text] [Related]
11. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556 [TBL] [Abstract][Full Text] [Related]
12. α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion. Kreiseder B; Orel L; Bujnow C; Buschek S; Pflueger M; Schuett W; Hundsberger H; de Martin R; Wiesner C Int J Cancer; 2013 Feb; 132(3):521-30. PubMed ID: 22733455 [TBL] [Abstract][Full Text] [Related]
13. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. Sin WC; Bechberger JF; Rushlow WJ; Naus CC J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727 [TBL] [Abstract][Full Text] [Related]
14. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231 [TBL] [Abstract][Full Text] [Related]
15. Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis. Krenacs T; Kiszner G; Stelkovics E; Balla P; Teleki I; Nemeth I; Varga E; Korom I; Barbai T; Plotar V; Timar J; Raso E Histochem Cell Biol; 2012 Oct; 138(4):653-67. PubMed ID: 22688676 [TBL] [Abstract][Full Text] [Related]
16. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Shellman YG; Makela M; Norris DA Melanoma Res; 2006 Jun; 16(3):207-11. PubMed ID: 16718267 [TBL] [Abstract][Full Text] [Related]
17. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis. Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes. Henrot P; Pain C; Taïeb A; Truchetet ME; Cario M Pigment Cell Melanoma Res; 2020 Nov; 33(6):895-898. PubMed ID: 32633087 [TBL] [Abstract][Full Text] [Related]
19. Keratinocyte-derived laminin-332 promotes adhesion and migration in melanocytes and melanoma. Chung H; Suh EK; Han IO; Oh ES J Biol Chem; 2011 Apr; 286(15):13438-47. PubMed ID: 21349841 [TBL] [Abstract][Full Text] [Related]
20. The expression of ccn3(nov) gene in musculoskeletal tumors. Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]